Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Albany Molecular Research AMRI

Healthcare Biotechnology
"Albany Molecular Research Inc is a contract research and manufacturing company, providing customers drug discovery, development and manufacturing services."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AMRI)

3ST Research Files Litigation Alleging Fraud and Conversion of Inventor's Intellectual Property Rights by Albany Molecular Research Inc. (AMRI)

PR Newswire September 12, 2017

Technical Snapshots for These Biotech Stocks -- Alnylam Pharma, Alexion Pharma, Albany Molecular Research, and BioCryst Pharma

PR Newswire September 8, 2017

AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR

PR Newswire August 31, 2017

20 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  August 18, 2017

Control4 Set to Join S&P SmallCap 600

PR Newswire August 17, 2017

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Albany Molecular Research, Inc. – AMRI

GlobeNewswire July 17, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Albany Molecular Research, Inc. (AMRI)

PR Newswire July 13, 2017

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Albany Molecular Research, Inc. - AMRI

PR Newswire July 5, 2017

Lifshitz & Miller LLP Announces Investigation of Albany Molecular Research, Inc., Atwood Oceanics, Inc., CardConnect Corp., Covisint Corporation, Sajan, Inc., Whole Foods Market, Inc. and Xactly Corporation

PR Newswire July 3, 2017
View More News ››

Opinion & Analysis (NDAQ:AMRI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AMRI)

Be the first to post on this bullboard.

Delphx Capital Markets Inc.

Delphx Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of ...
View More »